Atar Singh Kushwah

Biochemistry — Icahn School of Medicine at Mount Sinai, United States

LeadR Profile

Atar Singh Kushwah Icahn School of Medicine at Mount Sinai United States
84 ScienceLeadR Reputation 84
Network Map

Biochemistry

Subspecialties: Oncology - Hematology - Genetics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Short Biography

Dr. Atar Singh Kushwah is an Assistant Professor at Manipal University Jaipur and an internationally trained molecular geneticist specializing in translational oncology. His research integrates DNA repair, cancer epigenetics, and host–microbiome interactions to develop precision biomarkers and therapeutic strategies for women's cancers.

I investigate how DNA repair, epigenetic regulation, and host–microbiome interactions shape cancer evolution and therapeutic response. My goal is to translate molecular discoveries into clinically relevant biomarkers and precision therapies that improve patient outcomes.


Organizations

Career arc: 2014 - 2026

Source: PubMed

Manipal University Jaipur

could not re-read experiences after save", error); return null; } if (persistedEntries === null) { return null; } if (persistedEntries.length === 0 && sent.some((entry) => entry.isvisible !== false)) { console.warn(" re-read after save came back empty, keeping the edited entries"); return null; } this.state.current.experience = persistedEntries; const expected = this.yearsSignature(sent); const received = this.yearsSignature(persistedEntries.map((entry) => ({ isvisible: entry.isvisible, topresent: entry.topresent, year_start: entry.startperiod, year_stop: entry.endperiod }))); if (expected !== received) { console.error(" saved experiences were not persisted as sent", { sent: expected, received: received }); return false; } return true; }, async fetchExperiences() { const response = await $.ajax({ url: ajaxLoadUserData, type: "POST", data: { security: ajaxDataLoadUserData.security, data_to_load: "OrganizationHisto", } }); const parsedData = JSON.parse(response); if (parsedData.loaded === false || !parsedData.user_data || !Array.isArray(parsedData.user_data)) { return null; } return parsedData.user_data.map((value, index) => ({ company: value["name"], url: "", position: (value.hasOwnProperty("position") ? ( value["position"] ) : ( "" ) ), startperiod: value["year_start"], endperiod: value["year_stop"], topresent: (value.hasOwnProperty("topresent") ? ( value["topresent"] ) : ( false ) ), orgid: value["orgid"], isvisible: (value.hasOwnProperty("isvisible") ? ( value["isvisible"] ) : ( true ) ), description: "", tags: [], isOpen: false, ismain: (value.hasOwnProperty("ismain") ? ( value["ismain"] ) : ( (index === 0) ? true : false ) ) })); }, async loadDataOnMount() { this.loading = true; try { const experiences = await this.fetchExperiences(); this.loadFailed = experiences === null; if (experiences !== null) { this.state.current.experience = experiences; } } catch (error) { console.warn(" could not load experiences", error); this.loadFailed = true; } this.loading = false; } }, computed: { experience: { get() { return this.state.current.experience }, }, }, async mounted() { await this.loadDataOnMount() }, } }; })

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 31

Citations

Citations: 231 1st author: 10 Last author: 3 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
An overview of CRISPR-artificial intelligence theranostics: Current and emerging applications.
genes, intelligence, clustered regularly interspaced short palindromic repeats, point-of-care systems, rna, guide, kinetoplastida, biomarkers, nucleic acids, therapeutics, artificial intelligence, point-of-care testing
Biomater Transl20250
Personalized Neoantigen Cancer Vaccines: Why Clinical Benefit Remains Inconsistent.
vaccines, neoplasms, cancer vaccines
Crit Rev Oncol Hematol20260
MicroRNAs and HPV oncogenes crosstalk, their biomarker potential and therapeutic utility in cervical cancer.
oncogenes, uterine cervical neoplasms, micrornas, neoplasms, biomarkers, therapeutics, alphapapillomavirus, human papillomavirus viruses
Biomark Med20250
Genetic and epigenetic landscape of O 6-methylguanine-DNA methyltransferase (MGMT): implications for DNA repair and cancer therapeutics.
methyltransferases, o(6)-methylguanine-dna methyltransferase, dna repair, promoter regions, genetic, neoplasms, multiple chronic conditions, biomarkers, therapeutics, dna
Explor Target Antitumor Ther20257
Aurora kinases signaling in cancer: from molecular perception to targeted therapies.
cells, aurora kinases, mitosis, neoplasms, perception, therapeutics
Mol Cancer Top journal20250

LeadR Networks

Main global connection map